Copertina

Machine Learning‐Based Discovery of a Novel Noncovalent MurA Inhibitor as an Antibacterial Agent

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Qingxin Liu, Aoqi Luo, Hongwei Jin, Xinxin Si, Ming Li
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Chemical Biology & Drug Design
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Design and Synthesis of Novel MEK Inhibitors for the Treatment of Solid Tumors
di: Jingting Zeng, et al.
Pubblicazione: (2025)

Synthesis of Novel Thiazole/Thiadiazole Conjugates of Fluoroquinolones as Potent Antibacterial and Antimycobacterial Agents
di: Pınar Poyraz Yılmaz, et al.
Pubblicazione: (2025)

Coumarin‐Augmented Thiazole Hybrids as Dual Anticancer and Antibacterial Agents
di: Islam K. Matar, et al.
Pubblicazione: (2026)

Discovery of Novel Oxadiazole‐Triazole Hybrids as Lung and Cervical Cancer Agents: Synthesis, Docking, Biological Evaluation, and SAR Studies
di: Venkatraman Hegde, et al.
Pubblicazione: (2025)

Binding Mode Based Chemical Screening Method Utilizing D‐Ala‐D‐Ala Silica Gel Facilitating the Discovery of Overlooked Binding Affinity and Antibacterial Activity
di: Aoi Kimishima, et al.
Pubblicazione: (2026)

Chromone Derivatives as a Novel NOX4 Inhibitor: Design, Synthesis, and Regulation of ROS in Renal Fibroblast
di: Siming Wu, et al.
Pubblicazione: (2024)

Structure‐Based Design of 2‐Aminopyrazolpyrimidopyridone Derivatives as New Rearranged During Transfection (RET) Kinase Inhibitors
di: Jiayi Shen, et al.
Pubblicazione: (2024)

Design, Docking, ADMET , Pass, Synthesis and Bio‐Evaluation of Novel 7‐ O ‐Substituted Chrysin‐Based VEGFR ‐2 Inhibitors
di: Kalyani R. Thombre, et al.
Pubblicazione: (2026)

Discovery of Voreloxin as a Dual‐Selective Stabilizer for c‐Myc/Bcl‐2 G‐Quadruplexes in Leukemia
di: Jiacheng Yin, et al.
Pubblicazione: (2024)

Design and Synthesis of 1,4‐Diformyl‐Piperazine Ferrostatin‐1 Derivatives as Novel Ferroptosis Inhibitors
di: Yi‐Fan Zhang, et al.
Pubblicazione: (2024)

Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α‐Glucosidase Inhibitor and Their Molecular Docking Studies
di: Nurul Alam Inayatsyah, et al.
Pubblicazione: (2024)

Comprehensive Analysis of NADH:Ubiquinone Oxidoreductase Subunit B3 in Gynecological Tumors and Identification of Its Natural Inhibitor Wedelolactone
di: Huiping Li, et al.
Pubblicazione: (2024)

Novel Triazole‐Linked Indole Derivatives as Potent Soluble Epoxy Hydrolase Inhibitors With Promising Anticancer Activity
di: Vijaykumar D. Nimbarte, et al.
Pubblicazione: (2025)

Novel Hexahydropyrimidine Derivatives as Potential Neutral Sphingomyelinase 2 Inhibitors: Synthesis, Metal Chelation, and In Silico Studies
di: Ozge Kuyrukcu Ozturk, et al.
Pubblicazione: (2026)

Comment on “Integrative Analysis of Ex Vivo Studies and Microarray Reveals the Novel Inhibitor Effects of Trehalose on the Pathogenesis of Pterygium”
di: Thiago Gonçalves dos Santos Martins
Pubblicazione: (2024)

Computationally Driven Exploration of Novel bis‐Thiadiazole Sulfonamides as Alzheimer's Enzyme Inhibitors: A DFT and Kinetic Perspective
di: Farman Ullah, et al.
Pubblicazione: (2025)

From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors
di: Shiying Zhang, et al.
Pubblicazione: (2025)

Mollugin Derivatives as Anti‐Inflammatory Agents: Design, Synthesis, and NF‐κB Inhibition
di: Yuan‐Liang Gao, et al.
Pubblicazione: (2024)

Pharmacophore‐Based Identification and Molecular Characterization of Potent Neprilysin Inhibitors: Biochemical and Therapeutic Implications for Cardiovascular Diseases
di: Chung‐Ting Kuo, et al.
Pubblicazione: (2026)

Synthesis and Antitumor Evaluation of a Novel Class of Chalcone Mannich Base Derivatives
di: Bing He, et al.
Pubblicazione: (2025)

Multi‐Omics and Machine Learning‐Driven Discovery of ABCC8 ( SUR1 ) for Diabetes Mellitus: Integrating Molecular Insights on Nigella sativa Bioactives and Sulfonylurea
di: Mohd Adnan, et al.
Pubblicazione: (2026)

Novel Hydrazide‐Hydrazones Bearing a Benzimidazole Ring: Design, Synthesis, and Evaluation of Inhibitor Properties Against CA I and CA II Isozymes
di: Ayşen Işık, et al.
Pubblicazione: (2024)

High‐Throughput Platform for Discovery of Chemical Inhibitors of Heat Shock Protein 70 (Hsp70): Adaptation for the Specialized Bacterial HscA–HscB–IscU Complex
di: Arielle Shkedi, et al.
Pubblicazione: (2026)

Design and Synthesis of 2‐Aminopyrazolpyrimidopyridone Derivatives as RET V 804 M and RET G 810 C Kinase Inhibitors
di: Jiayi Shen, et al.
Pubblicazione: (2025)

An AI ‐Guided Structure‐Based Strategy for the Discovery and Biological Validation of Natural Products Targeting the Vitamin D Receptor From YSQYP in Diabetic Kidney Disease
di: Xinze Liu, et al.
Pubblicazione: (2026)

Identification of Potent Leucine‐Rich Repeat Kinase 2 Inhibitors by Virtual Screening and Biological Evaluation
di: Hualiang Shen, et al.
Pubblicazione: (2025)

Structural Insights Into Papain‐Derived Synthetic Antibacterial Peptides for Targeting Klebsiella pneumoniae
di: Marcos Antônio Ferreira, et al.
Pubblicazione: (2025)

Design, Synthesis, Computational Modeling and Biological Evaluation of Novel N‐( 7 H ‐Pyrrolo[2,3‐ d ]pyrimidin‐4‐yl)cinnamamides as Potential Covalent Inhibitors for Oncology
di: Rameshwar S. Cheke, et al.
Pubblicazione: (2025)

Multimodal Fusion of mpMRI Radiomics, Clinical Features, and Hematological Biomarkers Enhances Machine Learning‐Based Prediction of Biochemical Recurrence in Prostate Cancer Patients
di: Yinxing Zhu, et al.
Pubblicazione: (2025)

Novel Donepezil–Chalcone Hybrids as Potential Multifunctional Anti‐Alzheimer’s Disease Agents: Design, Synthesis, Computational Simulation, and In Vitro/In Vivo Biological Evaluation
di: Zhiqi Lin, et al.
Pubblicazione: (2026)

Novel Benzimidazole‐Urea Phenylalanine Hybrids as Dual‐Acting Antimicrobial and Anticancer Agents: In Silico and Biological Evaluation
di: Tuğçe Deniz Karaca, et al.
Pubblicazione: (2026)

Design, Hemisynthesis, Computational, and Biological Evaluation of Novel Totarol‐1,3‐Thiazol Derivatives as Anticancer Agents
di: Ayoub Boualli, et al.
Pubblicazione: (2026)

Design and Development of Novel Hybrids Based on Pyrrolo[2,1‐f][1,2,4]Triazine and 1‐(Methylpiperidin‐4‐yl) Aniline–Based Analogs: Exploring the Utility as Anticancer Agents via MERTK Inhibition
di: Balaji Dashrath Sathe, et al.
Pubblicazione: (2024)

The Immuno‐Metabolic Crosstalk in Lung Squamous Cell Carcinoma: Prognostic Insights and Therapeutic Clues
di: Haoyuan Xue, et al.
Pubblicazione: (2026)

Molecular Mechanisms and Efficacy of Tislelizumab, a PD ‐1 Inhibitor Developed in China, in Non‐Small Cell Lung Cancer
di: Yihao Liu, et al.
Pubblicazione: (2026)

Discovery of New 4‐Aminoquinoline–Thiazolidinone Hybrid Analogs as Antiproliferative Agents Inhibiting TLR4–LPS‐Mediated Migration in Triple‐Negative Breast Cancer Cells
di: S. K. Batin Rahaman, et al.
Pubblicazione: (2025)

Spacered With Tetrazole Oleanolic and Ursolic Indolo‐Acids Are Strong Inhibitors of α‐Glucosidase
di: Anastasiya V. Petrova, et al.
Pubblicazione: (2025)

Novel Phenoxyacetic Acid (4‐Aminophenoacetic Acid) Shikonin Ester Kills KRAS Mutant Colon Cancer Cells via Targeting the Akt Allosteric Site
di: Yudi Ma, et al.
Pubblicazione: (2025)

Design and Synthesized 3,4‐Dimethoxybenzene‐Based Fibrate Derivatives as Potential Hypolipidemic and Liver Protection Agents
di: Ling Ding, et al.
Pubblicazione: (2025)

Network Pharmacology, Machine Learning, Molecular Docking, and Cell Experiments Reveal the Therapeutic Mechanism of Radix Rehmanniae Praeparata in Psoriasis In Vitro
di: Tingting Zhang, et al.
Pubblicazione: (2026)